[On the production of anti-human-lymphocyte serum (ALS) by means of combined local and intravenous immunization in swine].
Lymphocytes of donors' peripheral blood were used for the study of pig antihuman ALS preparation by means of local and intravenous immunization. The results were compared with those obtained with exclusively local application of the same antigen. Antisera were tested from the aspect of activity (lymphoagglutination, lymphocytotoxicity, the rosette inhibition test) and for the presence of unwanted antibodies (haemagglutinins, thromboagglutinins, precipitins to serum proteins). Of all alternatives tested the following scheme proved to be optimal: subcutaneous application of 2 X 10(9) lymphocytes with adjuvans on day 0, followed by intravenous application of the same dosage on day 13, and serum harvesting on day 20. Antisera thus obtained displayed titres 1: 32 000 to 1 : 130 000 in the RIT - this being maximum level reached by exclusively local immunization only in some animals. Therefore, favourable immunosuppressive effect in vivo can be expected. Even more profound difference was observed in the level of unwanted antibodies that were found to be on markedly lower level after combined immunization. There is a good reason to suppose that with the help of further techniques, more likely absorption, these can be lowered to acceptable level. It is apparent from the results that with the help of a suitable immunization procedure not only highly active ALS can be obtained but also formation of nondesirable antibodies can be suppressed and, despite their thrombocyte contamination peripheral blood lymphocytes can successfully be used.
D000818:Animals; D000941:Antigens; D000961:Antilymphocyte Serum; D001792:Blood Platelets / Q000276:immunology; D006388:Hemagglutinins / Q000032:analysis; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008214:Lymphocytes / Q000276:immunology; D013552:Swine
D000941:Antigens; D000961:Antilymphocyte Serum; D006388:Hemagglutinins
Untersuchungen zur Produktion von antihumanlymphozytärem Serum (ALS) mittels kombinierter lokaler und intravenöser Immunisierung bei Schweinen